Trial Information
Adjustment of Optimal Immune System by Using Cytokine Cocktails Before Applying DC Vaccine
Inclusion Criteria:
- For observational study: health volunteers and cancer patients
- For DC vaccine: patients with solid tumor
Exclusion Criteria:
- leukemia
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Outcome Measure:
Immune status
Outcome Time Frame:
5 years
Safety Issue:
Yes
Principal Investigator
I-Hsuan A Chen, D.Phil
Investigator Role:
Principal Investigator
Investigator Affiliation:
Mackay Memorial Hospital
Authority:
Taiwan: Department of Health
Study ID:
MMH-I-S-321
NCT ID:
NCT00521287
Start Date:
October 2006
Completion Date:
December 2009
Related Keywords:
- Neoplasms
- Immunologic Surveillance
- Vaccination
- Immunotherapy
- Dendritic Cells
- Neoplasms
- Cytomegalovirus Infections
